Paper Dynamic changes in vascular size and density in transgenic mice with Alzheimer's disease

被引:11
|
作者
Xu, Xiaowen [1 ,2 ,3 ]
Meng, Tong [3 ]
Wen, Qingqing [4 ]
Tao, Mengling [2 ,3 ]
Wang, Peijun [2 ,3 ]
Zhong, Kai [5 ,6 ,7 ]
Shen, Yong [1 ]
机构
[1] Univ Sci & Technol China, Div Life & Med Sci,CAS Key Lab Brain Funct & Brai, Neurodegenerat Disorder Res Ctr,Hefei Mat Sci Nat, Inst Aging & Brain Disorders,Univ Affiliated Hosp, Hefei, Peoples R China
[2] Tongji Univ, Tongji Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[3] Tongji Univ, Sch Med, Shanghai, Peoples R China
[4] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Dept Biomed Engn, Key Lab Biomed Engn,Minist Educ, Hangzhou, Zhejiang, Peoples R China
[5] Chinese Acad Sci, High Magnet Field Lab, Hefei, Peoples R China
[6] Key Lab Anhui Prov High Field Magnet Resonance Im, Hefei, Peoples R China
[7] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
来源
AGING-US | 2020年 / 12卷 / 17期
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Alzheimer's disease; hippocampus; magnetic resonance imaging; vessel size imaging; early diagnosis; APP23; AGE; MICROVASCULATURE; DEPOSITION; MORPHOLOGY; PATHOLOGY; DEMENTIA; MODEL; MRI;
D O I
10.18632/aging.103672
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Here, we used vessel size imaging to investigate the specific microvascular changes and most susceptible brain regions during AD progression in an amyloid precursor protein 23 (APP23) transgenic AD mouse model. Using 9.4 Tesla magnetic resonance imaging (MRI), the values of microvascular density (Density), mean vessel diameter (mVD), and vessel size index (VSI) were compared between APP23 and wild-type (WT) mice at 3, 6, 9, 14, and 20 months of age. Our results demonstrate that in 20-month old APP23 and WT mice, the Density values were significantly decreased, while the vascular dilatation and diameter had increased. However, a transient increase in the cortex Density at 14-months was observed in APP23 mice. Additionally, our results suggest that the hippocampus is the susceptible brain region affected by the abnormal microvascular angiogenesis during the early stages of AD. Together, our findings indicate that vessel size imaging using MRI can provide novel biomarkers for the early detection of AD, and for monitoring the effects of vascular-targeted therapeutics in AD.
引用
收藏
页码:17224 / 17234
页数:11
相关论文
共 50 条
  • [21] Microbiome Alterations and Alzheimer's Disease: Modeling Strategies with Transgenic Mice
    Lopez-Villodres, Juan Antonio
    Escamilla, Alejandro
    Mercado-Saenz, Silvia
    Alba-Tercedor, Carmen
    Rodriguez-Perez, Luis Manuel
    Arranz-Salas, Isabel
    Sanchez-Varo, Raquel
    Bermudez, Diego
    BIOMEDICINES, 2023, 11 (07)
  • [22] Dynamics of Behavioral Disorders in Transgenic Mice with Modeled Alzheimer's Disease
    Semina, I. I.
    Baichurina, A. Z.
    Makarova, E. A.
    Leushina, A. V.
    Kazakevich, Zh. V.
    Gabdrakhmanova, M. R.
    Mukhamed'yarov, M. A.
    Zefirov, A. L.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 158 (05) : 621 - 623
  • [23] Transgenic Mice as a Model of Pre-Clinical Alzheimer's Disease
    Ferretti, M. T.
    Partridge, V.
    Leon, W. C.
    Canneva, F.
    Allard, S.
    Arvanitis, D. N.
    Vercauteren, F.
    Houle, D.
    Ducatenzeiler, A.
    Klein, W. L.
    Glabe, C. G.
    Szyf, M.
    Cuello, A. C.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (01) : 4 - 23
  • [24] MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice
    Thomas M. Wengenack
    Clifford R. Jack
    Michael Garwood
    Joseph F. Poduslo
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 82 - 88
  • [25] Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice
    Manocha, Gunjan D.
    Floden, Angela M.
    Miller, Nicole M.
    Smith, Abbie J.
    Nagamoto-Combs, Kumi
    Saito, Takashi
    Saido, Takaomi C.
    Combs, Colin K.
    NEUROBIOLOGY OF AGING, 2019, 81 : 166 - 176
  • [26] Reduced Membrane Lipids in the Cortex of Alzheimer's Disease Transgenic Mice
    Yao, Jeffrey K.
    Wengenack, Thomas M.
    Curran, Geoffry L.
    Poduslo, Joseph F.
    NEUROCHEMICAL RESEARCH, 2009, 34 (01) : 102 - 108
  • [27] Alzheimer's disease in man and transgenic mice - Females at higher risk
    Turner, RS
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03): : 797 - 801
  • [28] Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography
    Reiman, EM
    Uecker, A
    Gonzalez-Lima, F
    Minear, D
    Chen, KW
    Callaway, NL
    Berndt, JD
    Games, D
    NEUROREPORT, 2000, 11 (05) : 987 - 991
  • [29] Insights on the Use of Transgenic Mice Models in Alzheimer's Disease Research
    Padua, Mafalda Soares
    Guil-Guerrero, Jose L.
    Prates, Jose A. M.
    Lopes, Paula Alexandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [30] Reduced Membrane Lipids in the Cortex of Alzheimer’s Disease Transgenic Mice
    Jeffrey K. Yao
    Thomas M. Wengenack
    Geoffry L. Curran
    Joseph F. Poduslo
    Neurochemical Research, 2009, 34 : 102 - 108